» Authors » Marco Rosichini

Marco Rosichini

Explore the profile of Marco Rosichini including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 13
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bordoni V, Guarracino F, Galaverna F, Bertaina V, Li Pira G, Rosichini M, et al.
Blood Adv . 2024 Dec; 9(5):990-1002. PMID: 39626282
γδ T cells represent key players in immune surveillance after T-cell receptor α/β (αβ)/CD19-depleted HLA-haploidentical hematopoietic stem cell transplantation (haplo-HSCT). Although encouraging data are available on the impact of Vδ2-targeting...
2.
Rosichini M, Del Baldo G, De Luca C, Benini F, Genah S, Vinci M, et al.
NPJ Precis Oncol . 2024 Nov; 8(1):269. PMID: 39567679
Optimal immune function is crucial in preventing cancer development and growth and for the success of anti-cancer therapies. Here, we characterized the peripheral immunological status of 83 steroids-naïve pediatric patients...
3.
Galaverna F, Flamini S, De Luca C, Pili I, Boccieri E, Benini F, et al.
Haematologica . 2024 May; 109(10):3222-3236. PMID: 38813718
Mucosal-associated invariant T (MAIT) cells are innate-like T cells implicated in the response to fungal and bacterial infections. Their contribution to restoring T-cell immunity and influencing hematopoietic stem cell transplant...
4.
Patel S, Zhdanovskaya N, Sergio I, Cardinale A, Rosichini M, Varricchio C, et al.
Int J Mol Sci . 2024 Feb; 25(3). PMID: 38338689
T-cell acute lymphoblastic leukemia (T-ALL) is a hematological cancer characterized by the infiltration of immature T-cells in the bone marrow. Aberrant NOTCH signaling in T-ALL is mainly triggered by activating...
5.
Rosichini M, Bordoni V, Silvestris D, Mariotti D, Matusali G, Cardinale A, et al.
J Allergy Clin Immunol . 2023 Feb; 151(4):911-921. PMID: 36758836
Background: Lymphopenia, particularly when restricted to the T-cell compartment, has been described as one of the major clinical hallmarks in patients with coronavirus disease 2019 (COVID-19) and proposed as an...
6.
Rosichini M, Catanoso M, Screpanti I, Felli M, Locatelli F, Velardi E
Front Immunol . 2022 Jun; 13:920306. PMID: 35734178
Optimal recovery of immune competence after periods of hematopoietic insults or stress is crucial to re-establish patient response to vaccines, pathogens and tumor antigens. This is particularly relevant for patients...